Homes
Public Notices
News
Local news
Editor’s Pick
Pittsburgh
Local Government
Roads, Travel and Traffic
20 Years of Gas Drilling
Regional
U.S. and World
Business
Sports
HS Sports
College Sports
Penguins
Pirates
Steelers
Athlete of the Week
Wild Things
Pony Baseball
Outdoors
Columns
Opinion
Columns
Editorials
Letters to the Editor
Op Eds
Living
Neighbors
School News
Entertainment
Home and Garden
Food
Police Beat
Obituaries
Classifieds
Legal Notices
Sponsored Content
e-Edition
close
Washington County
Greene County
Mon Valley
News
Local news
Police Beat
Pittsburgh
Local Government
Roads, Travel and Traffic
Helping The Helpers
20 Years of Gas Drilling
Regional
U.S. and World
Business News
Sports
High School Sports
College Sports
Penguins
Pirates
Steelers
Wild Things
Pro Sports
Outdoors
Sports Column
Obituaries
Opinion
Columns
Editorials
Letters to the Editor
Op-Ed
Living
Neighbors
Health and Wellness
Entertainment
Home and Garden
Classifieds
Contact Us
Advertise With Us
Customer Service
Contact Information
Submission Forms
Statement of Values
Misc
Special Sections
Events
Sponsored Content
Newsletter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Panbela Therapeutics, Inc. - Common Stock
(OP:
PBLA
)
0.0111
-0.0090 (-44.78%)
Streaming Delayed Price
Updated: 12:17 PM EDT, Oct 20, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
868
Open
0.0350
Bid (Size)
N/A (0)
Ask (Size)
N/A (0)
Prev. Close
0.0201
Today's Range
0.0111 - 0.0350
52wk Range
0.0002 - 0.4729
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Panbela to Host Third Quarter 2024 Earnings Conference Call on November 14, 2024
October 31, 2024
From
Panbela Therapeutics, Inc.
Via
GlobeNewswire
First Patient Enrolled in Phase I Program in STK11 Mutant Non-Small Cell Lung Cancer at Moffitt Cancer Center
September 24, 2024
From
Panbela Therapeutics, Inc.
Via
GlobeNewswire
Performance
YTD
-97.5%
-97.5%
1 Month
-77.8%
-77.8%
3 Month
-93.0%
-93.0%
6 Month
-96.5%
-96.5%
1 Year
-96.7%
-96.7%
More News
Read More
PBLA Stock Earnings: Panbela Therapeutics Beats EPS for Q2 2024
August 14, 2024
Via
InvestorPlace
Panbela to Host Second Quarter 2024 Earnings Conference Call on Aug 13, 2024
July 30, 2024
From
Panbela Therapeutics, Inc.
Via
GlobeNewswire
Panbela Therapeutics Announces Third Independent Safety Review of Phase 3 ASPIRE Clinical Trial DSMB Recommended Continuation with No Trial Modification
June 24, 2024
From
Panbela Therapeutics, Inc.
Via
GlobeNewswire
Panbela Announces Oral Presentation at Digestive Disease Week (DDW):
June 10, 2024
From
Panbela Therapeutics, Inc.
Via
GlobeNewswire
Frequently Asked Questions
Is Panbela Therapeutics, Inc. - Common Stock publicly traded?
Yes, Panbela Therapeutics, Inc. - Common Stock is publicly traded.
What exchange does Panbela Therapeutics, Inc. - Common Stock trade on?
Panbela Therapeutics, Inc. - Common Stock trades on the OTC Traded
What is the ticker symbol for Panbela Therapeutics, Inc. - Common Stock?
The ticker symbol for Panbela Therapeutics, Inc. - Common Stock is PBLA on the OTC Traded
What is the current price of Panbela Therapeutics, Inc. - Common Stock?
The current price of Panbela Therapeutics, Inc. - Common Stock is 0.0111
When was Panbela Therapeutics, Inc. - Common Stock last traded?
The last trade of Panbela Therapeutics, Inc. - Common Stock was at 10/20/25 12:17 PM ET
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
Starting at $3.75
/
week.
Subscribe Today